A New Normal? Continued Impact of COVID19 on Alzheimer’s Clinical Trials Research

The COVID-19 pandemic has led to unprecedented challenges in Alzheimer’s disease and related dementias (ADRD) clinical trials research. Scientists continue to grapple with the potential and multifaceted consequences of COVID-19. This presentation will discuss strategies used at a U.S. Alzheimer’s Di...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhodus, Elizabeth, Gibson, Allison, Bardach, Shoshana, Abner, Erin, Jicha, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682056/
http://dx.doi.org/10.1093/geroni/igab046.527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682056/
http://dx.doi.org/10.1093/geroni/igab046.527

Ejemplares similares